Clinical Trial Update: Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of Ro 27-2441 as an inhaled corticosteroid replacement in moderate persistent asthma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Ro 27-2441

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 2 | Status: COMPLETED